Shockwave Medical, Inc. (NASDAQ:SWAV) Stake Lifted by International Assets Investment Management LLC

International Assets Investment Management LLC lifted its position in Shockwave Medical, Inc. (NASDAQ:SWAV - Free Report) by 18,122.1% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 141,586 shares of the company's stock after purchasing an additional 140,809 shares during the period. International Assets Investment Management LLC owned 0.38% of Shockwave Medical worth $26,981,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Covestor Ltd lifted its holdings in Shockwave Medical by 484.9% during the third quarter. Covestor Ltd now owns 427 shares of the company's stock worth $85,000 after buying an additional 354 shares during the period. American Century Companies Inc. lifted its holdings in Shockwave Medical by 109.0% during the third quarter. American Century Companies Inc. now owns 170,866 shares of the company's stock worth $34,019,000 after buying an additional 89,094 shares during the period. AMI Asset Management Corp purchased a new stake in Shockwave Medical during the fourth quarter worth $4,092,000. Wellington Management Group LLP lifted its holdings in Shockwave Medical by 33.5% during the third quarter. Wellington Management Group LLP now owns 1,805,771 shares of the company's stock worth $359,529,000 after buying an additional 453,048 shares during the period. Finally, Legato Capital Management LLC purchased a new stake in Shockwave Medical during the fourth quarter worth $280,000. Hedge funds and other institutional investors own 95.35% of the company's stock.

Shockwave Medical Price Performance

SWAV traded up $0.38 during trading on Friday, reaching $330.38. The company's stock had a trading volume of 810,028 shares, compared to its average volume of 2,058,974. The company has a quick ratio of 10.73, a current ratio of 11.76 and a debt-to-equity ratio of 1.09. The firm has a fifty day simple moving average of $301.64 and a two-hundred day simple moving average of $238.01. Shockwave Medical, Inc. has a 1 year low of $157.00 and a 1 year high of $331.58. The company has a market cap of $12.39 billion, a price-to-earnings ratio of 85.37, a PEG ratio of 2.45 and a beta of 0.88.

Shockwave Medical (NASDAQ:SWAV - Get Free Report) last posted its earnings results on Thursday, February 15th. The company reported $1.16 earnings per share for the quarter, beating the consensus estimate of $0.92 by $0.24. The firm had revenue of $202.98 million during the quarter, compared to the consensus estimate of $199.43 million. Shockwave Medical had a net margin of 20.17% and a return on equity of 23.97%. The firm's revenue for the quarter was up 41.0% on a year-over-year basis. During the same quarter last year, the firm earned $3.71 EPS. As a group, analysts anticipate that Shockwave Medical, Inc. will post 4.94 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on SWAV. Wolfe Research reiterated a "peer perform" rating on shares of Shockwave Medical in a report on Friday, April 5th. Wells Fargo & Company increased their price objective on Shockwave Medical from $200.00 to $210.00 and gave the company an "equal weight" rating in a report on Friday, February 16th. Piper Sandler upped their target price on Shockwave Medical from $290.00 to $360.00 and gave the company an "overweight" rating in a research report on Tuesday, April 2nd. Needham & Company LLC reaffirmed a "hold" rating on shares of Shockwave Medical in a research report on Friday, April 5th. Finally, TheStreet raised Shockwave Medical from a "c+" rating to a "b" rating in a research report on Thursday, February 15th. Ten equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $309.11.

Insider Transactions at Shockwave Medical

In related news, CEO Douglas Evan Godshall sold 10,000 shares of the firm's stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $231.56, for a total value of $2,315,600.00. Following the sale, the chief executive officer now owns 162,762 shares of the company's stock, valued at $37,689,168.72. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other Shockwave Medical news, Director Frank T. Watkins sold 2,000 shares of the stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $231.76, for a total value of $463,520.00. Following the transaction, the director now directly owns 4,532 shares in the company, valued at $1,050,336.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Douglas Evan Godshall sold 10,000 shares of the stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $231.56, for a total transaction of $2,315,600.00. Following the completion of the transaction, the chief executive officer now owns 162,762 shares in the company, valued at $37,689,168.72. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 86,407 shares of company stock valued at $22,081,356. 3.40% of the stock is currently owned by corporate insiders.

Shockwave Medical Company Profile

Shockwave Medical, Inc, a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels.